Effects of Mindfulness and Breathing Exercises in University Students
NCT07916025, Not applicable, Completed, Alanya Alaaddin Keykubat University
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Effects of Mindfulness and Breathing Exercises in University Students | ClinicalTrials.gov |
| NCT number | NCT07916025 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 106 participants, actual | ClinicalTrials.gov |
| Lead sponsor | Alanya Alaaddin Keykubat University | ClinicalTrials.gov |
| Conditions | Anxiety and Worry, Exam Anxiety, Self Esteem, Breathing Exercise | ClinicalTrials.gov |
| Interventions | Guided Mindfullness Group, Breathing Exercise Group | ClinicalTrials.gov |
| First posted | 2026-11-04 | ClinicalTrials.gov |
| Last updated | 2026-11-04 | ClinicalTrials.gov |
Registered outcomes 5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Change in Five Facet Mindfulness Questionnaire-Short Form (FFMQ-SF) Total Score | Baseline (before the five-day study period) and Day 5 (immediately after completion of the five-day study period) | Dispositional mindfulness was assessed using the Turkish version of the Five Facet Mindfulness Questionnaire-Short Form (FFMQ-SF). This self-report questionnaire contains 20 items rated on a five-point scale from 1 to 5. After appropriate reverse scoring, total scores range from 20 to 100, with higher scores indicating greater mindfulness. Change was calculated as the post-intervention total score minus the baseline total score. Positive change values indicate increased mindfulness, whereas negative values indicate decreased mindfulness. | ClinicalTrials.gov |
| Secondary | Change in State-Trait Anxiety Inventory State Anxiety Subscale (STAI-S) Total Score | Baseline (before the five-day study period) and Day 5 (immediately after completion of the five-day study period) | State anxiety was assessed using the state anxiety subscale of the Turkish State-Trait Anxiety Inventory (STAI-S). This 20-item self-report scale measures anxiety at the time of assessment. Items are rated on a four-point scale from 1 to 4. After appropriate reverse scoring, total scores range from 20 to 80, with higher scores indicating greater state anxiety. Change was calculated as the post-intervention total score minus the baseline total score. Negative change values indicate reduced anxiety. | ClinicalTrials.gov |
| Secondary | Change in State-Trait Anxiety Inventory Trait Anxiety Subscale (STAI-T) Total Score | Baseline (before the five-day study period) and Day 5 (immediately after completion of the five-day study period) | Trait anxiety was assessed using the trait anxiety subscale of the Turkish State-Trait Anxiety Inventory (STAI-T). This 20-item self-report scale measures the general tendency to experience anxiety across situations. Items are rated on a four-point scale from 1 to 4. After appropriate reverse scoring, total scores range from 20 to 80, with higher scores indicating greater trait anxiety. Change was calculated as the post-intervention total score minus the baseline total score. Negative change values indicate reduced anxiety. | ClinicalTrials.gov |
| Secondary | Change in Multidimensional Test Anxiety Scale (MTAS) Total Score | Baseline (before the five-day study period) and Day 5 (immediately after completion of the five-day study period) | Test anxiety was assessed using the Turkish version of the Multidimensional Test Anxiety Scale (MTAS). This 16-item self-report scale covers worry, cognitive interference, tension, and physiological indicators of test anxiety. Items are rated on a five-point scale from 1 to 5. Total scores range from 16 to 80, with higher scores indicating greater test anxiety. Change was calculated as the post-intervention total score minus the baseline total score. Negative change values indicate reduced test anxiety. | ClinicalTrials.gov |
| Secondary | Change in Rosenberg Self-Esteem Scale (RSES) Total Score | Baseline (before the five-day study period) and Day 5 (immediately after completion of the five-day study period) | Self-esteem was assessed using the 10-item Rosenberg Self-Esteem Scale (RSES). Responses were scored from 0 to 3, with appropriate reverse scoring applied to obtain a summated total score ranging from 0 to 30. Higher scores indicate greater self-esteem. Change was calculated as the post-intervention total score minus the baseline total score. Positive change values indicate increased self-esteem, whereas negative values indicate decreased self-esteem. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)